Abstract
Triple A syndrome (TAS) or Allgrove syndrome (OMIM #231550) is a rare autosomal recessive disorder characterised by adrenocorticotropic hormone-resistant adrenal insufficiency, alacrima, achalasia, and neurological and dermatological abnormalities. Mutations in the AAAS gene on chromosome 12q13 encoding the nuclear pore protein ALADIN have been reported in these patients. Between 2006 and 2017, we evaluated six patients with a clinical diagnosis of TAS, based on the presence of at least two symptoms, usually adrenal insufficiency and alacrima. In all cases, genetic analysis revealed homozygous mutations in the AAAS gene. One novel mutation was detected: a homozygous 10-bp deletion (c.1264_1273del, p.Q422NfsX126) in exon 14 of the AAAS gene that caused a frameshift that introduced an aberrant stop codon after 126 amino acids. This genetic variant is likely to be pathogenic because it caused a significant change in protein structure. A precise genotype–phenotype correlation was impossible to establish.
Conclusions: Based on our experience, we recommend that molecular analysis should be performed in the presence of alacrima and at least one more symptom of TAS. Our cases share many clinical features of TAS and underline the variability in this syndrome, as well as the need for thorough investigation following a multidisciplinary approach.
What is known: • Triple A syndrome is characterised by achalasia, alacrima, adrenal insufficiency, neurological impairment, and dermatological abnormalities. • A precise genotype–phenotype correlation has proved impossible to establish. |
What is new: • These cases add to a large number of similar case reports with limited novel information. • The newly identified AAAS gene mutation was reported. |
Similar content being viewed by others
Abbreviations
- ACTH :
-
Adrenocorticotropic hormone
- ALADIN :
-
Alacrima, Achalasia, Adrenal Insufficiency, Neurological Disorder
- DTR :
-
Deep tendon reflexes
- NPC :
-
Nuclear pore complex
- PRA :
-
Plasma renin activity
- WD :
-
Tryptophan–aspartic acid
- TAS :
-
Triple A syndrome
References
Allgrove J, Clayden GS, Grant DB, Macaulay JC (1978) Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1(8077):1284–1286
Appak YÇ, Çam FS, Evirgen Şahin G, Uluçay S, Huebner A, Kasırga E (2014) Triple A syndrome with clinical and genetic findings: a case report. Çocuk Sağlığı ve Hastalıkları Dergisi 57:195–199
Brown B, Agdere L, Muntean C, David K (2016) Alacrima as a harbinger of adrenal insufficiency in a child with Allgrove (AAA) syndrome. Am J Case Rep 17:703–706. https://doi.org/10.12659/AJCR.899546
Dumić M, Barišić N, Rojnić-Putarek N, Kušec V, Stanimirović A, Koehler K, Huebner A (2011) Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Eur J Pediatr 170(3):393–396. https://doi.org/10.1007/s00431-010-1314-4
Dumic M, Barišic N, Kusec V, Stingl K, Skegro M, Stanimirovic A, Koehler K, Huebner A (2012) Long-term clinical follow-up and molecular genetic findings in eight patients with triple a syndrome. Eur J Pediatr 171(10):1453–1459. https://doi.org/10.1007/s00431-012-1745-1
Goizet C, Catargi B, Tison F, Tullio-Pelet A, Hadj-Rabia S, Pujol F, Lagueny A, Lyonnet S, Lacombe D (2002) Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology 58(6):962–965. https://doi.org/10.1212/WNL.58.6.962
Grant DB, Barnes ND, Dumic M, Ginalska-Malinowska M, Milla PJ, von Petrykowski W, Rowlatt RJ, Steendijk R, Wales JH, Werder E (1993) Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome. Arch Dis Child 68(6):779–782. https://doi.org/10.1136/adc.68.6.779
Guran T, Buonocore F, Saka N, Ozbek MN, Aycan Z, Bereket A, Bas F, Darcan S, Bideci A, Guven A, Demir K, Akinci A, Buyukinan M, Aydin BK, Turan S, Agladioglu SY, Atay Z, Abali ZY, Tarim O, Catli G, Yuksel B, Akcay T, Yildiz M, Ozen S, Doger E, Demirbilek H, Ucar A, Isik E, Ozhan B, Bolu S, Ozgen IT, Suntharalingham JP, Achermann JC (2016) Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrinol Metab 101(1):284–292. https://doi.org/10.1210/jc.2015-3250
Hallal C, Kieling CO, Nunes DL, Ferreira CT, Peterson G, Barros SG, Arruda CA, Fraga JC, Goldani HA (2012) Diagnosis, misdiagnosis, and associated diseases of achalasia in children and adolescents: a twelve-year single center experience. Pediatr Surg Int 28(12):1211–1217. https://doi.org/10.1007/s00383-012-3214-3
Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A (2001) Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 10(3):283–290. https://doi.org/10.1093/hmg/10.3.283
Houlden H, Smith S, De Carvalho M, Blake J, Mathias C, Wood NW, Reilly MM (2002) Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 125(12):2681–2690. https://doi.org/10.1093/brain/awf270
Milenkovic T, Zdravkovic D, Savic N, Todorovic S, Mitrovic K, Koehler K, Huebner A (2010) Triple A syndrome: 32 years experience of a single centre (1977-2008). Eur J Pediatr 169(11):1323–1328. https://doi.org/10.1007/s00431-010-1222-7
Misgar RA, Pala NA, Ramzan M, Wani AI, Bashir MI, Laway BA (2015) Allgrove (triple A) syndrome: a case report from the Kashmir Valley. Endocrinol Metab (Seoul) 30(4):604–606. https://doi.org/10.3803/EnM.2015.30.4.604
Papageorgiou L, Mimidis K, Katsani KR, Fakis G (2013) The genetic basis of triple A (Allgrove) syndrome in a Greek family. Gene 512(2):505–509. https://doi.org/10.1016/j.gene.2012.10.008
Phillip M, Hershkovitz E, Schulman H (1996) Adrenal insufficiency after achalasia in the triple-A syndrome. Clin Pediatr (Phila) 35(2):99–100. https://doi.org/10.1177/000992289603500208
Prasad R, Metherell LA, Clark AJ, Storr HL (2013) Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology 154(9):3209–3218. https://doi.org/10.1210/en.2013-1241
Prpic I, Huebner A, Persic M, Handschug K, Pavletic M (2003) Triple A syndrome: genotype-phenotype assessment. Clin Genet 63(5):415–417. https://doi.org/10.1034/j.1399-0004.2003.00070.x
Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, Huebner A, Clark AJ (2009) Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol 23(12):2086–2094. https://doi.org/10.1210/me.2009-0056
Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C, Bégeot M, Naville D, Nicolino M, Chaussain JL, Weissenbach J, Munnich A, Lyonnet S (2000) Mutant WD-repeat protein in triple-A syndrome. Nat Genet 26(3):332–335. https://doi.org/10.1038/81642
Weber A, Wienker TF, Jung M, Easton D, Dean HJ, Heinrichs C, Reis A, Clark AJ (1996) Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum Mol Genet 5(12):2061–2066. https://doi.org/10.1093/hmg/5.12.2061
Wente SR, Rout MP (2010) The nuclear pore complex and nuclear transport. Cold Spring Harb Perspect Biol 2:a000562
Author information
Authors and Affiliations
Contributions
Study concept and design: EK, PD, ZA, MB, and SC. Acquisition of data: EK, ZA, SSE, NMS, MK, EB, MB, and SC. Analysis and interpretation of data: EK, PD, and MB. Drafting the manuscript: EK and MB. Critical revision of the manuscript for important intellectual content: EK, MB, and SC. Final approval of the version to be published: all authors.
Corresponding author
Ethics declarations
Ethical approval
The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Local Ethics Committee.
Informed consent
Blood samples from patients and family members were collected for genetic testing after obtaining written informed consent.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Communicated by Peter de Winter
Rights and permissions
About this article
Cite this article
Kurnaz, E., Duminuco, P., Aycan, Z. et al. Clinical and genetic characterisation of a series of patients with triple A syndrome. Eur J Pediatr 177, 363–369 (2018). https://doi.org/10.1007/s00431-017-3068-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-017-3068-8